ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2801

Optimal Threshold of Walking Speed Predictive of Mortality Risk over 9 Years in Knee Osteoarthritis: Data from Osteoarthritis Initiative

Hiral Master1, Tuhina Neogi 2, Lavalley Michael 3, Louise Thoma 4, Meredith Christiansen 5, Dana Voinier 5, Lauren Neely 5, Jason Jakiela 5 and Daniel White 1, 1University of Delaware, Newark, DE, 2Boston University School of Medicine, Boston, MA, 3Boston University, Boston, 4University of North Carolina at Chapel Hill, Newark, 5University of Delaware, Newark

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Mortality, Osteoarthritis, walking speed and thresholds

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: 5T098: Orthopedics, Low Back Pain & Rehabilitation (2798–2803)

Session Type: ACR/ARP Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Knee osteoarthritis (OA) is associated with mortality, and walking difficulty is known to mediate this relationship. However, little is known about what specific aspects of walking difficulty increase mortality risk. We investigated the relationship of walking speed, as a measure of walking difficulty, to mortality and studied what thresholds that best discriminate risk of mortality in people with knee OA. Since knee OA frequently occurs in mid-life, we additionally investigated if walking speed is a relevant predictor of mortality and studied the thresholds that best discriminate the mortality risk in younger adults (aged < 65 years) with knee OA.

Methods: We used data from the Osteoarthritis Initiative (OAI). Walking speed was measured via the 20-meter (m) walk test. We quantified time to mortality over 9 years, i.e., until the 108-month OAI visit. To examine the association of walking speed with mortality over 9 years, we calculated hazard ratios (HR) and 95% confidence intervals (CI) from the Cox regression model adjusted for potential confounders. To identify an optimal threshold of walking speed predictive of mortality risk, we used the Maximal Likelihood Ratio Chi-square Approach. This approach selects the threshold that is most concordant with mortality risk over the observed follow-up times, a metric similar to maximizing Youden index when using a receiver operating curve method. Specifically, we ran adjusted Cox regression models for different thresholds of the walking speed iteratively. We then identified the optimal threshold from the model that yielded the maximal chi-square value (Table). We repeated these analyses separately for younger adults with knee OA.

Results: Of 4775 participants who completed the 20-m walk at baseline (age [mean (± sd)] 61.1 ± 9.2 years, BMI 28.6 ± 4.8 kg/m2, 59% female), 6.5% (312/4755) died over 9 years.  For younger adults, 3.0% (88/2966) died. Walking 0.1 meters/second (m/s) slower during the 20-m walk was associated with 16% [Adjusted HR 1.16, 95% CI (1.09, 1.23)] and 14% [Adjusted HR 1.14, 95% CI (1.02, 1.28)] higher risk of  mortality over 9 years in the overall analytic sample and younger adults, respectively. Walking slower than 1.2 m/s was found to be an optimal threshold to best discriminate those with and without mortality for both the entire cohort, and among younger adults (Table).

Conclusion: Walking speed, an objective measure of walking difficulty is associated with mortality in knee OA. Specifically, walking slower than 1.2 m/s during a 20-m walk test may identify the risk of mortality in people with OA. These same thresholds also apply to younger adults with knee OA. Thus, walking speed may be a simple indicator of health in adults with knee OA. Health care professionals may use walking speed to assess expected health and tailor goals of care for knee OA population.

Table: Maximal Likelihood Ratio Chi-Square Approach^ to identify the optimal threshold of walking speed that predicted the risk of mortality in A- overall sample and B- younger adults with or at risk of knee OA


Disclosure: H. Master, None; T. Neogi, MerckSerono, 5, Novartis, 5; L. Michael, None; L. Thoma, None; M. Christiansen, None; D. Voinier, None; L. Neely, None; J. Jakiela, None; D. White, None.

To cite this abstract in AMA style:

Master H, Neogi T, Michael L, Thoma L, Christiansen M, Voinier D, Neely L, Jakiela J, White D. Optimal Threshold of Walking Speed Predictive of Mortality Risk over 9 Years in Knee Osteoarthritis: Data from Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/optimal-threshold-of-walking-speed-predictive-of-mortality-risk-over-9-years-in-knee-osteoarthritis-data-from-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/optimal-threshold-of-walking-speed-predictive-of-mortality-risk-over-9-years-in-knee-osteoarthritis-data-from-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology